Protocol, rationale and design of DAbigatran for Stroke PreVention In Atrial Fibrillation in MoDerate or Severe Mitral Stenosis (DAVID-MS): a randomised, open-label study

INTRODUCTION: Current international guidelines recommend non-vitamin K oral anticoagulants (NOACs) for stroke prevention among patients with non-valvular atrial fibrillation (AF) at significant ischaemic stroke risk given the superior safety and comparable efficacy of NOACs over warfarin. Nonetheles...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Mi, Chan, Esther W, Hai, Jo Jo, Wong, Chun Ka, Lau, Yuk Ming, Huang, Duo, Lam, Cheung Chi, Tam, Chor Cheung Frankie, Wong, Yiu Tung Anthony, Yung, See Yue Arthur, Chan, Ki Wan Kelvin, Feng, Yingqing, Tan, Ning, Chen, Ji-yan, Yung, Chi Yui, Lee, Kwok Lun, Choi, Chun Wai, Lam, Ho, Ng, Andrew, Fan, Katherine, Jim, Man Hong, Yiu, Kai Hang, Yan, Bryan P., Siu, Chung Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520829/
https://www.ncbi.nlm.nih.gov/pubmed/32978200
http://dx.doi.org/10.1136/bmjopen-2020-038194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520829/
https://www.ncbi.nlm.nih.gov/pubmed/32978200
http://dx.doi.org/10.1136/bmjopen-2020-038194

Ejemplares similares